| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
Jiyun Lee, Joon Ho Shim, Woong-Yang Park, Hee Kyung Kim, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat. 2019;51(1):408-412.   Published online May 23, 2018    DOI: https://doi.org/10.4143/crt.2018.138
                              Supplementary         Cited By 2
Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
Jun Ma, Xiao Song, Xiaowu Xu, Yiping Mou
Cancer Res Treat. 2019;51(1):194-210.   Published online April 20, 2018    DOI: https://doi.org/10.4143/crt.2018.031
                              Supplementary      
CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
Hui Chang, Jia-wang Wei, Ya-lan Tao, Pei-rong Ding, Yun-fei Xia, Yuan-hong Gao, Wei-wei Xiao
Cancer Res Treat. 2018;50(4):1203-1213.   Published online December 21, 2017    DOI: https://doi.org/10.4143/crt.2017.538
                              Supplementary         Cited By 2
Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
Ziqian Li, Kaying Chan, Yifei Qi, Linlin Lu, Fen Ning, Mengling Wu, Haifang Wang, Yuan Wang, Shaohui Cai, Jun Du
Cancer Res Treat. 2018;50(3):894-907.   Published online September 18, 2017    DOI: https://doi.org/10.4143/crt.2017.356
                              Supplementary      
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
Cancer Res Treat. 2018;50(1):239-254.   Published online March 24, 2017    DOI: https://doi.org/10.4143/crt.2016.580
                                 Cited By 8
Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
Jae-Hyeon Kim, Jun-Ho Ahn, Michael Lee
Cancer Res Treat. 2017;49(4):947-959.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.280
                              Supplementary         Cited By 7
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
Young-Bem Se, Seung Hyun Kim, Ji Young Kim, Ja Eun Kim, Yun-Sik Dho, Jin Wook Kim, Yong Hwy Kim, Hyun Goo Woo, Se-Hyuk Kim, Shin-Hyuk Kang, Hak Jae Kim, Tae Min Kim, Soon-Tae Lee, Seung Hong Choi, Sung-Hye Park, Il Han Kim, Dong Gyu Kim, Chul-Kee Park
Cancer Res Treat. 2017;49(2):387-398.   Published online July 19, 2016    DOI: https://doi.org/10.4143/crt.2016.106
                              Supplementary         Cited By 6
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Breast Cancers
So Jeong Lee, Cheong-Soo Hwang, Young-Keum Kim, Hyun Jung Lee, Sang-Jeong Ahn, Nari Shin, Jung Hee Lee, Dong Hoon Shin, Kyung Un Choi, Do Youn Park, Chang Hun Lee, Gi Young Huh, Mi Young Sol, Hee Jin Lee, Gyungyub Gong, Jee Yeon Kim, Ahrong Kim
Cancer Res Treat. 2017;49(2):313-321.   Published online July 7, 2016    DOI: https://doi.org/10.4143/crt.2016.098
                                 Cited By 2
Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Jae Cheol Lee, Seung Hun Jang, Kye Young Lee, Young-Chul Kim
Cancer Res Treat. 2013;45(2):79-85.   Published online June 30, 2013    DOI: https://doi.org/10.4143/crt.2013.45.2.79
                                 Cited By 12
Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells
Hana Yu, Junseong Park, Jungsul Lee, Kyungsun Choi, Chulhee Choi
Cancer Res Treat. 2012;44(3):195-201.   Published online September 30, 2012    DOI: https://doi.org/10.4143/crt.2012.44.3.195
                                 Cited By 9
Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
Fariz Nurwidya, Fumiyuki Takahashi, Akiko Murakami, Kazuhisa Takahashi
Cancer Res Treat. 2012;44(3):151-156.   Published online September 30, 2012    DOI: https://doi.org/10.4143/crt.2012.44.3.151
                                 Cited By 80
Present Status and Problems on Molecular Targeted Therapy of Cancer
Nagahiro Saijo
Cancer Res Treat. 2012;44(1):1-10.   Published online March 31, 2012    DOI: https://doi.org/10.4143/crt.2012.44.1.1
                                 Cited By 15
Characterization of RhoA-mediated Chemoresistance in Gastric Cancer Cells
Won Ki Kang, Inkyoung Lee, Chaehwa Park
Cancer Res Treat. 2005;37(4):251-256.   Published online August 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.4.251
                                 Cited By 7
cDNA Microarray Analysis of Differential Gene Expression in Gastric Cancer Cells Sensitive and Resistant to 5-Fluorouracil and Cisplatin
Myung-Ju Ahn, Young-Do Yoo, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Ho-Suck Oh, Jung-Hye Choi, Yong-Sung Lee
Cancer Res Treat. 2005;37(1):54-62.   Published online February 28, 2005    DOI: https://doi.org/10.4143/crt.2005.37.1.54
                                 Cited By 3
The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray
Myung-Ju Ahn, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Jung-Hye Choi, Joung Soon Jang, Jong Min Bae, Yong-Sung Lee
Cancer Res Treat. 2004;36(1):43-49.   Published online February 29, 2004    DOI: https://doi.org/10.4143/crt.2004.36.1.43
                                 Cited By 4
Expressions of Multidrug Resistance-Related Genes in Gastric Cancer Tissue and Normal Gastric Mucosal Tissue
Seok Hun Song, Sang Woon Kim, Sun Kyo Song, Joon Hyuk Choi, Jeoung Hee Ha, Kyung Hee Lee
Cancer Res Treat. 2001;33(4):302-308.   Published online August 31, 2001    DOI: https://doi.org/10.4143/crt.2001.33.4.302
      
Expression of P53, Bcl-2, Bax, and P-glycoprotein in Relation to Chemotherapeutic Response in Patients with Advanced Non-Small-Cell Lung Cance
Suk Young Park, Eun Hee Lee, Kee Won Kim, Chul Seung Kay, Seok Chan Kim, Ji Won Suhr, Kyung Shick Lee
J Korean Cancer Assoc. 2001;33(2):158-162.
      
N-nitrosomorpholine Directed Preneoplastic Reprogramming of Nuclear Metabolism of Rat Hepatocytes
Min Chan Kim, Jin Sook Jeong, Yong Chun Choi, Ghap Joong Jung, Sang Soon Kim
J Korean Cancer Assoc. 2000;32(6):1075-1083.
      
Clinicopathologic Significance of Multidrug Resistance Protein Expression in Patients with Stage III Gastric Adendegrees Carcinoma
Sae Hyun Kim, Wan Ku Lee, Hyun Kim, Young Nam Kim, Seung Min Park, Su Jin Choi, Hyo Suk Park, Myung Jin Joo, Kwang Min Lee, Jong Myung Lee, Sung Hye Shin, Min Chul Kim
J Korean Cancer Assoc. 2000;32(3):487-496.
      
Drug Resistance to 5 - Fluorouracil and Overexpression of Thymidylate Synthase mRNA in Human Gastrointestinal Malignancies
Tae You Kim, Baek Yeol Ryoo, Yung Hyuck Im, Yoon Koo Kang, Sang Jae Lee, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc. 2000;32(1):44-52.
      
Effects of New Nultidrug - Resistance Reversing Agent, KR-30035, on Tumoral Uptake of Tc-99m MIBI In-vitro and In-vivo
Ihn Ho Cho, Jaetae Lee, Jang Soo Suh, Byung Ho Lee, Sang Woon Choi, Sang Kyun Sohn, Chong Ock Lee, Sung Eun Yoo, June Key Chung, Kyu Bo Lee
J Korean Cancer Assoc. 1999;31(4):773-783.
      
A Phase 2 Trial of Verapamil for Reversal of Drug Resistance in Refractory Non - Hodgkin's Lymphoma
Keun Chil Park, Baek Yeol Ryoo, Young Hyuk Im, Sung Wook Kang, Jhin Oh Lee, Taik Koo Yun, Ho Sang Shin
J Korean Cancer Assoc. 1999;31(2):313-319.
      
Expression of Multidrug Resistant Genes in Bone Marrow Mononuclear Cells of Patients with Myeloid Leukemia
Seok Goo Cho, Il Ho Yang, Hyeon Seok Eom, Chang Gi Min, Hee Je Kim, Dong Wook Kim, Jong Wook Lee, Chi Wha Han, Woo Sung Min, Won Il Kim, Chun Choo Kim
J Korean Cancer Assoc. 1999;31(1):153-164.
      
TGFbeta1 Effect on Survival of Anticancer Drug - resistant L1210 Sublines
Sung Yong Kim, Kyung Sub Lee, Jae Ryong Kim, Jeong Hee Kim
J Korean Cancer Assoc. 1998;30(5):1005-1013.
      
GEnetic Change in Transforming Growth Factor-B (TGF-B) Receptor Type I and Type II Genes with Resistance to TGF-B of Human Breast Cancer Cells
Hwa Young Lee, Sung Sil Jeon, Hyun Ja Kwon, Soo Jung Kong, Seon Young Rah, Joong Bae Ahn, Kwang Yong Sim, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Kyung Sik Lee, Jin Sik Min, Byung Soo Kim, Hyun Chul Chung
J Korean Cancer Assoc. 1998;30(4):683-691.
      
Isolation of Differentially-Displayed cDNAs from a Doxrubicin Resistant Gastric Carcinoma Cell Line
Myung Soo Kang, Jae Ho Lee, Jae Gahb Park
J Korean Cancer Assoc. 1998;30(4):625-631.
      
Differential Mucin Gene Expression Associated with Methotrexate Resistance of Human Colonic Adenocarcinoma Cell Line, HT29
Bong Hwa Lee, Young S Kim
J Korean Cancer Assoc. 1997;29(6):977-983.
      
Expression and Clinical Relevance of c-erbB-3 in Rectal Cancer
Chong In Lee, Sun Young Rha, Jin Oh Park, Hyun Cheol Chung, Jae Yong Cho, Joong Bae Ahn, Nae Choon Yoon, Tae Soo Kim, Joo Hang Kim, Jae Kyung Roh, Jin Sup Choi, Jin Sik Min, Byung Soo Kim, Woo Ick Ja
J Korean Cancer Assoc. 1996;28(1):50-63.
      
Expression and Significance of c-erbB-2 in Radically Resected Colorectal Cancer
Hyun Cheol Chung, Sun Young Rha, Joon Oh Park, Seung Hun Song, Jae Yong Cho, Jung Bae Aha, Hye Ran Lee, Chong In Lee, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Jin Sil Seong, Gwi Eon Kim, Jin Sik M
J Korean Cancer Assoc. 1995;27(3):389-403.
      
Reversal Effect of Antihistamines on Multidrug Resistance in Adriamycin - and Vincristine - resistant L1210 Variants
Jae Ryong Kim, Sung Yong Kim, Jeong Hee Kim
J Korean Cancer Assoc. 1995;27(1):130-138.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community